Actively Recruiting
Effectiveness of Cognitive Behavioural Therapy With Melatonin for Chronic Insomnia in Older Adults A Randomized Controlled Study
Led by The University of Hong Kong · Updated on 2026-08-21
183
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
The trial investigates the effectiveness of cognitive behavioural therapy for insomnia CBT-I with or without melatonin in older adults aged 60 and above who have chronic insomnia. The purpose is to determine if adding melatonin to CBT-I improves sleep, circadian rhythms, and daytime functioning. This randomized, double-blind, placebo-controlled study compares three groups to clarify whether melatonin enhances CBT-I benefits in late-life sleep health. Participants are randomly assigned to one of three groups CBT-I plus nightly 3 mg immediate-release melatonin, CBT-I plus a placebo pill, or sleep health psychoeducation plus placebo. Each group attends four weekly in-person group sessions lasting 90 to 120 minutes. Melatonin or placebo tablets are taken 30 minutes before usual bedtime for four weeks. The study is conducted across two university sites. Participants undergo assessments at baseline, mid-treatment week 2, and post-treatment week 4, with follow-ups at three and six months for those in the CBT-I groups. Data collected include questionnaires on sleep, mood, fatigue, quality of life, and cognitive tests, as well as objective measures like actigraphy over seven nights, sleep diaries, polysomnography, and saliva samples for circadian timing in a subset. The primary outcome is change in self-reported insomnia severity, with many secondary measures of sleep, mood, cognition, and daytime function monitored throughout the study and follow-up.
CONDITIONS
Brief Title
Efficacy of CBT-I With Adjuvant Melatonin in Older Adults Chronic Insomnia
Research Team
S
Shirley Xin LI, DClinPsy, PhD
Z
Zihan Chen, MS
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here